Crawford Investment Counsel Inc. Has $16.48 Million Stock Position in The Clorox Company $CLX

Crawford Investment Counsel Inc. grew its position in The Clorox Company (NYSE:CLX) by 103.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 163,433 shares of the company’s stock after acquiring an additional 83,111 shares during the quarter. Crawford Investment Counsel Inc.’s holdings in Clorox were worth $16,479,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CLX. Vermillion & White Wealth Management Group LLC bought a new stake in shares of Clorox in the 3rd quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new stake in shares of Clorox in the 2nd quarter worth approximately $29,000. Vision Financial Markets LLC lifted its position in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares during the period. Ameriflex Group Inc. lifted its position in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after acquiring an additional 273 shares during the period. Finally, Elevated Capital Advisors LLC bought a new stake in shares of Clorox in the 4th quarter worth approximately $43,000. Institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.63% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Wells Fargo & Company reduced their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Evercore reiterated an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research report on Friday, May 1st. UBS Group reduced their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Finally, The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $103.40.

Clorox Trading Up 1.6%

Shares of CLX opened at $97.52 on Wednesday. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a 50 day simple moving average of $96.26 and a 200-day simple moving average of $105.05. The stock has a market cap of $11.79 billion, a PE ratio of 15.83, a PEG ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the firm posted $1.45 EPS. Clorox’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.